Ten experts on a NIH COVID-19 panel have ties to companies involved in coronavirus treatment

Eight members of NIH's COVID-19 Treatment Guidelines Panel list financial ties to Gilead Sciences, whose COVID-19 drug remdesivir has been touted by Dr. Anthony Fauci.